1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, September 2016 (p9)

Biological Therapy Analysis & Statistics, September 2016 (p9)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

241-270 of about 1100 reports

Purchase Reports From Reputable Market Research Publishers

International Stem Cell Corporation (ISCO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

International Stem Cell Corporation (ISCO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • September 2016
  • by Global Data

Summary International Stem Cell Corporation (ISCC) is a biotechnology company that develops technology solutions. The company develops parthenogenesis, which is a stem cell technology that improves the ...

  • Industries : Biological Therapy
Juvaris BioTherapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Juvaris BioTherapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • September 2016
  • by Global Data

Summary Juvaris BioTherapeutics, Inc. (Juvaris) is a pharmaceutical company that develops adjuvanted vaccines and immunotherapeutics to treat cancer and infectious disease in the fields of human and animal ...

  • Industries : Biological Therapy, Pharmaceutical
Japan Tissue Engineering Co., Ltd. (7774) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Japan Tissue Engineering Co., Ltd. (7774) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • September 2016
  • by Global Data

Summary Japan Tissue Engineering Co., Ltd. (J-TEC) is a pharmaceutical company that develops, manufactures and sells tissue-engineered medical products and related products. The company's products include ...

  • Industries : Pharmaceutical
  • Countries : Japan
Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2016

Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2016’, provides an overview ...

  • Industries : Cancer, Pathology, Therapy, Biopharmaceutical
  • Countries : United States
Allergic Rhinitis - Pipeline Review, H2 2016

Allergic Rhinitis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Allergic Rhinitis - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Allergic Rhinitis - Pipeline Review, H2 2016’, provides an overview of the Allergic Rhinitis pipeline landscape. The ...

  • Industries : Chronic Disease, Pathology
  • Countries : Japan, World, United States
Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2016

Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2016’, provides an overview of the Graft Versus ...

  • Industries : Blood Supply, Tissue Banking and Transplantation, Healthcare
  • Countries : United States
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H2 2016

Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline ...

  • Industries : Therapy, Pharmaceutical, Pathology
  • Countries : United States
Interleukin 17A (Cytotoxic T Lymphocyte Associated Antigen 8 or CTLA8 or IL17A) - Pipeline Review, H2 2016

Interleukin 17A (Cytotoxic T Lymphocyte Associated Antigen 8 or CTLA8 or IL17A) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Interleukin 17A (Cytotoxic T Lymphocyte Associated Antigen 8 or CTLA8 or IL17A) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Interleukin 17A (Cytotoxic T Lymphocyte Associated Antigen ...

  • Industries : Pathology
  • Countries : United States
Liver Fibrosis - Pipeline Review, H2 2016

Liver Fibrosis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Liver Fibrosis - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Liver Fibrosis - Pipeline Review, H2 2016’, provides an overview of the Liver Fibrosis pipeline landscape. The report provides ...

  • Industries : Pathology, Therapy, Pharmaceutical, Biotechnology
  • Countries : United States
2016 Cell Surface Markers: Emerging Opportunities, Country Forecasts, Innovative Technologies, Competitive Landscape--US, Europe (France, Germany, Italy, Spain, UK), Japan

2016 Cell Surface Markers: Emerging Opportunities, Country Forecasts, Innovative Technologies, Competitive Landscape--US, Europe (France, Germany, Italy, Spain, UK), Japan

  • $ 3500
  • Industry report
  • September 2016
  • by Venture Planning Group

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic ...

  • Industries : Biological Therapy
  • Countries : United States, Spain, France, Italy, United Kingdom, Japan
Tissue Therapies Limited (TIS) - Medical Equipment - Deals and Alliances Profile

Tissue Therapies Limited (TIS) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • September 2016
  • by Global Data

Summary Tissue Therapies Limited (TTL) is a heath biotechnology company that develops, manufactures and markets synthetic proteins. The company develops treatments for acute and chronic wound healing applications ...

  • Industries : Biological Therapy
U.S. Stem Cell, Inc. (USRM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

U.S. Stem Cell, Inc. (USRM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • September 2016
  • by Global Data

Summary U.S. Stem cell, Inc., (formerly Bioheart, Inc.) is a biotechnology company which focuses on the discovery, development and commercialization of cell based therapeutics products. The company repairs ...

  • Industries : Biological Therapy
  • Countries : United States
Antisense Therapeutics Limited (ANP) - Financial and Strategic SWOT Analysis Review

Antisense Therapeutics Limited (ANP) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • September 2016
  • by Global Data

Antisense Therapeutics Limited (ANP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled ...

  • Industries : Therapy, Biological Therapy
Stem Cell Therapies Market: By Therapy (Autologous & Allogeneic), By Applications (CNS, CVS, GIT, Wound Healing, Musculoskeletal, Eye, & Immune System) & By Geography -Forecast (2016-2021)

Stem Cell Therapies Market: By Therapy (Autologous & Allogeneic), By Applications (CNS, CVS, GIT, Wound Healing, Musculoskeletal, Eye, & Immune System) & By Geography -Forecast (2016-2021)

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Stem-cell therapy medical practice which is used to treat or prevent a disease or condition using stem cells.Recent inventions and R&D activities have shown that stem cells have tremendous promise to help ...

  • Industries : Pathology, Biological Therapy
Global Mesenchymal Stem Cells Industry

Global Mesenchymal Stem Cells Industry

  • $ 4950
  • Industry report
  • September 2016
  • by Global Industry Analysts

This report analyzes the worldwide markets for Mesenchymal Stem Cells in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. ...

  • Industries : Biological Therapy
  • Countries : United States, World, Europe, Japan
R&D and Business Tracker for Bispecific Antibodies

R&D and Business Tracker for Bispecific Antibodies

  • $ 1320
  • Industry report
  • September 2016
  • by La Merie Publishing

R&D and Business Tracker for Bispecific Antibodies- a monthly update service This information service about Bispecific Antibodies delivers 12 monthly update reports in pdf format by e-mail straight ...

  • Industries : Biological Therapy
Immunotherapy Drugs - Global Market Outlook (2016-2022)

Immunotherapy Drugs - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • September 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Immunotherapy Drugs market is accounted for $38.26 billion in 2015 and is expected to reach $97.47 billion by 2022 growing at a CAGR of 14.3%. In present scenario ...

  • Industries : Biological Therapy
  • Countries : World, Europe, North America, Asia
3D Cell Culture Technologies Patent Landscape

3D Cell Culture Technologies Patent Landscape

  • $ 5489
  • Company report
  • September 2016
  • by KnowMade

IP landscape for 3D cell culture technologies offers an important space to big entities as well as for small companies 3D CELL CULTURE : REPRODUCING AN IN VIVO-LIKE ENVIRONMENT IN VITRO The patent landscape ...

  • Industries : Biological Therapy, In Vitro Diagnostics
  • Countries : United States
Global RNAi Technologies Market Analysis & Trends - Industry Forecast to 2025

Global RNAi Technologies Market Analysis & Trends - Industry Forecast to 2025

  • $ 4200
  • Industry report
  • September 2016
  • by Accuray Research LLP

Global RNAi Technologies Market Analysis & Trends - Industry Forecast to 2025 The Global RNAi Technologies Market is poised to grow at a CAGR of around 20.4% over the next decade to reach approximately ...

  • Industries : Biological Therapy
  • Countries : World, Europe, Asia, North America
Global Regenerative Medicine Partnering 2010-2016: Deal trends, players, financials and forecasts

Global Regenerative Medicine Partnering 2010-2016: Deal trends, players, financials and forecasts

  • $ 2995
  • Industry report
  • September 2016
  • by Currentpartnering

The Global Regenerative Medicine Partnering 2010-2016: Deal trends, players, financials and forecasts report provides comprehensive understanding and unprecedented access to the regenerative medicine including ...

  • Industries : Biological Therapy, Biotechnology, Pathology, Healthcare, Therapy, Pharmaceutical
  • Countries : United States, North America
R&D and Business Tracker for TCR & CAR T-Cells and NK Cells

R&D and Business Tracker for TCR & CAR T-Cells and NK Cells

  • $ 1320
  • Industry report
  • September 2016
  • by La Merie Publishing

R&D and Business Tracker for TCR & CAR T-Cell and NK Cells - a monthly update service This information service about TCR & CAR engineered T-cells and NK cells delivers 12 monthly update reports in ...

  • Industries : Biological Therapy
Burns - Pipeline Review, H2 2016

Burns - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Burns - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Burns - Pipeline Review, H2 2016’, provides an overview of the Burns pipeline landscape. The report provides comprehensive information ...

  • Industries : Therapy, Pharmaceutical
  • Countries : United States, World, Europe
Myocardial Ischemia - Pipeline Review, H2 2016

Myocardial Ischemia - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Myocardial Ischemia - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Myocardial Ischemia - Pipeline Review, H2 2016’, provides an overview of the Myocardial Ischemia pipeline landscape. ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States, World, Russian Federation
Dystrophin (DMD) - Pipeline Review, H2 2016

Dystrophin (DMD) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Dystrophin (DMD) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Dystrophin (DMD) - Pipeline Review, H2 2016’, provides in depth analysis on Dystrophin (DMD) targeted pipeline therapeutics. ...

  • Industries : Therapy, Mental Health, Pathology, Pharmaceutical
  • Countries : United States, World
Melanocyte Protein PMEL (ME20M or Melanocyte Protein Pmel 17 or Melanocytes Lineage Specific Antigen GP100 or Melanoma Associated ME20 Antigen or P1 or P100 or Premelanosome Protein or Silver Locus Protein Homolog or PMEL) - Pipeline Review, H2 2016

Melanocyte Protein PMEL (ME20M or Melanocyte Protein Pmel 17 or Melanocytes Lineage Specific Antigen GP100 or Melanoma Associated ME20 Antigen or P1 or P100 or Premelanosome Protein or Silver Locus Protein Homolog or PMEL) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Melanocyte Protein PMEL (ME20M or Melanocyte Protein Pmel 17 or Melanocytes Lineage Specific Antigen GP100 or Melanoma Associated ME20 Antigen or P1 or P100 or Premelanosome Protein or Silver Locus Protein ...

  • Industries : Biopharmaceutical, Therapy, Biotechnology
  • Countries : United States, World
Bone Marrow Transplant Rejection - Pipeline Review, H2 2016

Bone Marrow Transplant Rejection - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Bone Marrow Transplant Rejection - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Bone Marrow Transplant Rejection - Pipeline Review, H2 2016’, provides an overview of the Bone Marrow ...

  • Industries : Blood Supply, Tissue Banking and Transplantation, Healthcare
  • Countries : United States
Grass Pollen Allergy - Pipeline Review, H2 2016

Grass Pollen Allergy - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Grass Pollen Allergy - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Grass Pollen Allergy - Pipeline Review, H2 2016’, provides an overview of the Grass Pollen Allergy pipeline landscape. ...

  • Industries : Therapy, Pharmaceutical
  • Countries : United States
Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2016

Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2016’, provides an overview of ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States
Alpha L-Iduronidase (IDUA or EC 3.2.1.76) - Pipeline Review, H2 2016

Alpha L-Iduronidase (IDUA or EC 3.2.1.76) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Alpha L-Iduronidase (IDUA or EC 3.2.1.76) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Alpha L-Iduronidase (IDUA or EC 3.2.1.76) - Pipeline Review, H2 2016’, provides in depth analysis ...

  • Industries : Biopharmaceutical, Therapy, Pathology, Biotechnology, Pharmaceutical
  • Countries : United States
Alpha- Antitrypsin Deficiency - Pipeline Review, H2 2016

Alpha- Antitrypsin Deficiency - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Alpha- Antitrypsin Deficiency - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Alpha- Antitrypsin Deficiency - Pipeline Review, H2 2016’, provides an overview of the Alpha- Antitrypsin ...

  • Industries : Biotechnology, Pathology, Therapy, Pharmaceutical
  • Countries : United States

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.